Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study

AN Phillips; V Cambiano; F Nakagawa; P Revill; MR Jordan; TB Hallett; M Doherty; A Luca; JD Lundgren; M Mhangara; T Apollo; J Mellors; B Nichols; U Parikh; D Pillay; TR de Wit; K Sigaloff; D Havlir; DR Kuritzkes; A Pozniak; David van de Vijver; M Vitoria; MA Wainberg; E Raizes; S Bertagnolio

doi:10.1016/s2352-3018(17)30190-x

Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study

AN Phillips, V Cambiano, F Nakagawa, P Revill, MR Jordan, TB Hallett, M Doherty, A Luca, JD Lundgren, M Mhangara, T Apollo, J Mellors, B Nichols, U Parikh, D Pillay, TR de Wit, K Sigaloff, D Havlir, DR Kuritzkes, A PozniakDavid van de Vijver, M Vitoria, MA Wainberg, E Raizes, S Bertagnolio

Virology

Research output: Contribution to journal › Article › Academic › peer-review

48 Citations (Scopus)

5 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	E146-E154
Journal	LANCET HIV
Volume	5
Issue number	3
DOIs	https://doi.org/10.1016/s2352-3018(17)30190-x
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s2352-3018(17)30190-x

REPUB_103128-OA.pdfFinal published version, 1.19 MB

http://hdl.handle.net/1765/103128

Cite this

Phillips, AN., Cambiano, V., Nakagawa, F., Revill, P., Jordan, MR., Hallett, TB., Doherty, M., Luca, A., Lundgren, JD., Mhangara, M., Apollo, T., Mellors, J., Nichols, B., Parikh, U., Pillay, D., de Wit, TR., Sigaloff, K., Havlir, D., Kuritzkes, DR., ... Bertagnolio, S. (2018). Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study. LANCET HIV, 5(3), E146-E154. https://doi.org/10.1016/s2352-3018(17)30190-x

@article{cd66fe16687f43f9bc1e338ca699bc43,

title = "Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study",

author = "AN Phillips and V Cambiano and F Nakagawa and P Revill and MR Jordan and TB Hallett and M Doherty and A Luca and JD Lundgren and M Mhangara and T Apollo and J Mellors and B Nichols and U Parikh and D Pillay and {de Wit}, TR and K Sigaloff and D Havlir and DR Kuritzkes and A Pozniak and {van de Vijver}, David and M Vitoria and MA Wainberg and E Raizes and S Bertagnolio",

year = "2018",

doi = "10.1016/s2352-3018(17)30190-x",

language = "Undefined/Unknown",

volume = "5",

pages = "E146--E154",

journal = "The Lancet HIV",

issn = "2352-3018",

publisher = "Elsevier Ltd.",

number = "3",

}

Phillips, AN, Cambiano, V, Nakagawa, F, Revill, P, Jordan, MR, Hallett, TB, Doherty, M, Luca, A, Lundgren, JD, Mhangara, M, Apollo, T, Mellors, J, Nichols, B, Parikh, U, Pillay, D, de Wit, TR, Sigaloff, K, Havlir, D, Kuritzkes, DR, Pozniak, A, van de Vijver, D, Vitoria, M, Wainberg, MA, Raizes, E & Bertagnolio, S 2018, 'Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study', LANCET HIV, vol. 5, no. 3, pp. E146-E154. https://doi.org/10.1016/s2352-3018(17)30190-x

TY - JOUR

T1 - Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study

AU - Phillips, AN

AU - Cambiano, V

AU - Nakagawa, F

AU - Revill, P

AU - Jordan, MR

AU - Hallett, TB

AU - Doherty, M

AU - Luca, A

AU - Lundgren, JD

AU - Mhangara, M

AU - Apollo, T

AU - Mellors, J

AU - Nichols, B

AU - Parikh, U

AU - Pillay, D

AU - de Wit, TR

AU - Sigaloff, K

AU - Havlir, D

AU - Kuritzkes, DR

AU - Pozniak, A

AU - van de Vijver, David

AU - Vitoria, M

AU - Wainberg, MA

AU - Raizes, E

AU - Bertagnolio, S

PY - 2018

Y1 - 2018

U2 - 10.1016/s2352-3018(17)30190-x

DO - 10.1016/s2352-3018(17)30190-x

M3 - Article

VL - 5

SP - E146-E154

JO - The Lancet HIV

JF - The Lancet HIV

SN - 2352-3018

IS - 3

ER -